Literature DB >> 16626861

Neuroactive steroids prevent peripheral myelin alterations induced by diabetes.

Sergio Veiga1, Emanuela Leonelli, Manolo Beelke, Luis M Garcia-Segura, Roberto C Melcangi.   

Abstract

The effect of the neuroactive steroids progesterone, dihydroprogesterone and tetrahydroprogesterone on myelin abnormalities induced by diabetes was studied in the sciatic nerve of adult male rats treated with streptozotocin. Streptozotocin increased blood glucose levels and decreased body weight gain, parameters not affected by steroids. Streptozotocin increased the number of fibers with myelin infoldings in the axoplasm, 8 months after the treatment. Chronic treatment for 1 month with progesterone and dihydroprogesterone resulted in a significant reduction in the number of fibers with myelin infoldings to control levels. Treatment with tetrahydroprogesterone did not significantly affect this myelin alteration. These results suggest that neuroactive steroids such as progesterone and dihydroprogesterone may represent therapeutic alternatives to counteract peripheral myelin alterations induced by diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16626861     DOI: 10.1016/j.neulet.2006.03.058

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  13 in total

1.  Dihydroprogesterone increases the gene expression of myelin basic protein in spinal cord of diabetic rats.

Authors:  Marzia Pesaresi; Silvia Giatti; Donato Calabrese; Omar Maschi; Donatella Caruso; Roberto Cosimo Melcangi
Journal:  J Mol Neurosci       Date:  2010-03-27       Impact factor: 3.444

2.  Evidences for antinociceptive effect of 17-α-hydroxyprogesterone caproate in carpal tunnel syndrome.

Authors:  Federica Ginanneschi; Paolo Milani; Georgios Filippou; Mauro Mondelli; Bruno Frediani; Roberto C Melcangi; Alessandro Rossi
Journal:  J Mol Neurosci       Date:  2011-11-24       Impact factor: 3.444

3.  Diabetes-induced myelin abnormalities are associated with an altered lipid pattern: protective effects of LXR activation.

Authors:  Gaia Cermenati; Federico Abbiati; Solei Cermenati; Elisabetta Brioschi; Alessandro Volonterio; Guido Cavaletti; Enrique Saez; Emma De Fabiani; Maurizio Crestani; Luis M Garcia-Segura; Roberto C Melcangi; Donatella Caruso; Nico Mitro
Journal:  J Lipid Res       Date:  2011-12-07       Impact factor: 5.922

4.  Progesterone - new therapy in mild carpal tunnel syndrome? Study design of a randomized clinical trial for local therapy.

Authors:  Paolo Milani; Mauro Mondelli; Federica Ginanneschi; Riccardo Mazzocchio; Alessandro Rossi
Journal:  J Brachial Plex Peripher Nerve Inj       Date:  2010-04-26

Review 5.  Neuroprotective actions of brain aromatase.

Authors:  Colin J Saldanha; Kelli A Duncan; Bradley J Walters
Journal:  Front Neuroendocrinol       Date:  2009-05-18       Impact factor: 8.606

6.  Antidiabetic effect of Withania coagulans in experimental rats.

Authors:  Dolly Jaiswal; Prashant Kumar Rai; Geeta Watal
Journal:  Indian J Clin Biochem       Date:  2009-05-08

7.  Neuroactive Steroid Levels in a transgenic rat model of CMT1A Neuropathy.

Authors:  Donatella Caruso; Samuele Scurati; Ilaria Roglio; Lucilla Nobbio; Angelo Schenone; Roberto C Melcangi
Journal:  J Mol Neurosci       Date:  2008-01-09       Impact factor: 3.444

Review 8.  Allopregnanolone and Progesterone in Experimental Neuropathic Pain: Former and New Insights with a Translational Perspective.

Authors:  Susana Laura González; Laurence Meyer; María Celeste Raggio; Omar Taleb; María Florencia Coronel; Christine Patte-Mensah; Ayikoe Guy Mensah-Nyagan
Journal:  Cell Mol Neurobiol       Date:  2018-09-05       Impact factor: 5.046

Review 9.  Neuroactive Steroids and Sex-Dimorphic Nervous Damage Induced by Diabetes Mellitus.

Authors:  Silvia Giatti; Silvia Diviccaro; Roberto Cosimo Melcangi
Journal:  Cell Mol Neurobiol       Date:  2018-08-14       Impact factor: 5.046

10.  Progesterone prevents development of neuropathic pain in a rat model: Timing and duration of treatment are critical.

Authors:  Liliane J Dableh; James L Henry
Journal:  J Pain Res       Date:  2011-04-05       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.